WebbGraduated from the Faculty of Medical Sciences of Santa Casa of Sao Paulo (1993), Medical Hospital of Aeronautics of Sao Paulo (1994), residency in general surgery (1995-1996), resident in surgery of the digestive system (1997-1998 ), specializing in abdominal organ transplantation (1999-2001), Master (2001-2003) in Medicine (Surgery), Faculty of … WebbFCXM+ recipients received induction therapy with lymphocyte-depleting agents (thymoglobulin or Campath) more often than did FCXM− recipients (83% vs. 50%, p < 0.001). Therefore, we performed additional analysis of graft outcomes stratified by induction agents .
Rabbit Antithymocyte Globulin versus Basiliximab in Renal ...
WebbWhile allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potential curative therapy against hematological malignancies, modulation of donor T cell alloreactivity is required to enhance the graft-versus-leukemia (GVL) effect and control graft-versus-host-disease (GVHD) after allo-HSCT. WebbCurrently, almost 70% of kidney-transplant recipients receive induction therapy with either rabbit antithymocyte globulin (Thymoglobulin, Genzyme), a lymphocyte-depleting … hacker\u0027s keyboard permissions
Pełny tekst: Significance of anti-endothelial cell antibodies in ...
Webb1 okt. 2008 · The effectiveness of cytolytic induction phase therapy after heart transplantation (HTx) continues to be debated. 1 Historically, published reports have … WebbThymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Trans-plantation 1998; 66: 29. 35. Brennan DC, Flavin K, Lowell JA, et al. A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients. Webb1 nov. 2024 · A 31-year-old male patient underwent allo-HSCT from a 9/10 HLA-matched male unrelated donor for acute myeloid leukemia (AML) in June 2024. He was diagnosed with AML and translocation t(9;11) six months earlier. The patient received induction chemotherapy consisted of daunorubicin and cytarabine. brahim elghouti